The week's biggest event arrives Wednesday. NVDA reports after the close on May 20 with a $5.4 trillion market cap. Expectations are enormous. Options traders are split — bears are hedging while bulls chase semi names hard. MACOM Technology Solutions and MaxLinear lead bullish options flow, up 119% and 430% YTD respectively. Analysts are also warming to chips. Lam Research and Ciena saw target price upgrades today, with Ciena's average target rising more than $16 to $440.54.
Ryanair posted a 40% jump in full-year profit to €2.26B. Revenue grew 11% to €15.54B. Fares rose 10% as the airline carried 208 million passengers. The result was the standout European print of the day.
AstraZeneca added two FDA approvals, including Baxfendy — a first-in-class hypertension drug. GSK won Japan approval for its RSV vaccine in a new patient group.
Anthropic is briefing global financial watchdogs on cyber vulnerabilities exposed by the Mythos incident. The briefing involves AMZN, GOOGL, and MSFT by association. AAPL faces a separate headache. An Indian court ordered the company to cooperate fully in an App Store antitrust probe. TSLA also drew scrutiny after two robotaxi crashes in Austin raised fresh questions about its autonomous driving rollout.
Elliott Management built a major stake in Bio-Rad Laboratories, the WSJ reported. Bill Gates separately filed over $93M in purchases of RSG. On the sell side, early backers of CRWV filed $150M+ in sales as post-IPO lockup pressure mounts.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
